Sorin to speed development of heart failure neuromodulation with Neurotech purchase
This article was originally published in Clinica
Executive Summary
Italian cardiovascular firm Sorin has acquired Belgian neurostimulation specialist Neurotech in a deal that should help it speed up development of its own neuromodulation therapies for heart failure. Financial details of the deal were not disclosed.